Meglumine antimonate: Difference between revisions

	WikiDoc Resources for Meglumine antimonate
Articles
Most recent articles on Meglumine antimonate Most cited articles on Meglumine antimonate Review articles on Meglumine antimonate Articles on Meglumine antimonate in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Meglumine antimonate Images of Meglumine antimonate Photos of Meglumine antimonate Podcasts & MP3s on Meglumine antimonate Videos on Meglumine antimonate
Evidence Based Medicine
Cochrane Collaboration on Meglumine antimonate Bandolier on Meglumine antimonate TRIP on Meglumine antimonate
Clinical Trials
Ongoing Trials on Meglumine antimonate at Clinical Trials.gov Trial results on Meglumine antimonate Clinical Trials on Meglumine antimonate at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Meglumine antimonate NICE Guidance on Meglumine antimonate NHS PRODIGY Guidance FDA on Meglumine antimonate CDC on Meglumine antimonate
Books
Books on Meglumine antimonate
News
Meglumine antimonate in the news Be alerted to news on Meglumine antimonate News trends on Meglumine antimonate
Commentary
Blogs on Meglumine antimonate
Definitions
Definitions of Meglumine antimonate
Patient Resources / Community
Patient resources on Meglumine antimonate Discussion groups on Meglumine antimonate Patient Handouts on Meglumine antimonate Directions to Hospitals Treating Meglumine antimonate Risk calculators and risk factors for Meglumine antimonate
Healthcare Provider Resources
Symptoms of Meglumine antimonate Causes & Risk Factors for Meglumine antimonate Diagnostic studies for Meglumine antimonate Treatment of Meglumine antimonate
Continuing Medical Education (CME)
CME Programs on Meglumine antimonate
International
Meglumine antimonate en Espanol Meglumine antimonate en Francais
Business
Meglumine antimonate in the Marketplace Patents on Meglumine antimonate
Experimental / Informatics
List of terms related to Meglumine antimonate

Meglumine antimonate
Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	P01CB01 (WHO) Template:ATCvet;
Identifiers
	IUPAC name Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol;
CAS Number	133-51-7 ;
PubChem CID	64953;
ChemSpider	58479 ;
ChEMBL	ChEMBL239129 ;
NIAID ChemDB	008733;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	Variable
Molar mass	Variable
3D model (JSmol)	Interactive image;
	SMILES O=[Sb](=O)O.O[C@@H]([C@@H](O)[C@H](O)[C@@H](O)CNC)CO;
	InChI InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1 ; Key:XOGYVDXPYVPAAQ-SESJOKTNSA-M ;
(what is this?) (verify)

VisualWikitext

Latest revision as of 16:40, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis.^[1] It is manufactured by Aventis^[2] and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

References

↑ PMID 9455509 (PMID 9455509)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
↑ Aventis press release, 15 April 2005. Template:De icon

Template:Excavata antiparasitics

Template:Antiinfective-drug-stub

[1] PMID 9455509 (PMID 9455509)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

[2] Aventis press release, 15 April 2005. Template:De icon

[1]

[2]

Meglumine antimonate: Difference between revisions

Latest revision as of 16:40, 20 August 2015

Overview

See also

References

Navigation menu

Revision as of 16:07, 15 April 2015 (view source) Rabin Bista (talk \| contribs) (Created page with "{{Drugbox \| Verifiedfields = changed \| verifiedrevid = 476995406 \| IUPAC_name = Hydroxy-dioxostiborane; (2''R'',3''R'',4''R'',5''S'')-6-methylaminohexane-1,2,3,4,5-pentol \| im...")	Latest revision as of 16:40, 20 August 2015 (view source) WikiBot (talk \| contribs) m (Protected "Meglumine antimonate": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)))
(No difference)